• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chinook Therapeutics, Inc. - Common Stock (NQ:KDNY)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 40.27 (1)
Ask (Size) 40.82 (1)
Prev. Close 40.39
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 66,889,369
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
August 11, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
 
Via Benzinga

Performance

More News

Read More
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
August 06, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Chinook Therapeutics Inc. (NASDAQ: KDNY) Highlighted for Surprising Price Action
August 01, 2023
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
August 01, 2023
Via Benzinga
Expert Ratings for Chinook Therapeutics
August 01, 2023
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
July 31, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
July 26, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm
July 21, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY
July 21, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm
July 16, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
July 10, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
July 05, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
July 05, 2023
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Is Investigating Chinook, DLocal, Comerica, and Advanced Auto Parts and Encourages Investors to Contact the Firm
June 30, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Bowlero, Integra, Chinook, and DLocal and Encourages Investors to Contact the Firm
June 24, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Why Shares of Vera Therapeutics Jumped Tuesday
June 20, 2023
Via The Motley Fool
2 Surging Healthcare Stocks With More Fuel in the Tank
June 20, 2023
Via The Motley Fool
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm
June 19, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
June 16, 2023
Via Investor's Business Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NexTier Oilfield Solutions Inc. (NYSE – NEX), Chinook Therapeutics, Inc. (Nasdaq – KDNY), Franchise Group, Inc. (Nasdaq – FRG), Greenhill & Co., Inc. (NYSE – GHL)
June 15, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, and DZS and Encourages Investors to Contact the Firm
June 14, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via Benzinga
CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY
June 13, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
June 13, 2023
Via Benzinga

Frequently Asked Questions

Is Chinook Therapeutics, Inc. - Common Stock publicly traded?
Yes, Chinook Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Chinook Therapeutics, Inc. - Common Stock trade on?
Chinook Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Chinook Therapeutics, Inc. - Common Stock?
The ticker symbol for Chinook Therapeutics, Inc. - Common Stock is KDNY on the Nasdaq Stock Market
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap